To read the full testimony of Dr. Cross, click here.
STATEMENT OF
GERALD M. CROSS, MD, FAAFP
PRINCIPAL DEPUTY
UNDER SECRETARY FOR HEALTH
BEFORE THE
SENATE COMMITTEE ON VETERANS’ AFFAIRS
MAY 21, 2008
Good Morning Mr. Chairman and Members of the Committee:
Thank you for inviting me here today to present the Administration’s views on a
number of bills that would affect Department of Veterans Affairs (VA) programs of
benefits and services. With me today are Walter A. Hall, Assistant General
Counsel, and Kathryn Enchelmayer, Director, Quality Standards, Office of Quality
and Performance. I am pleased to provide the Department’s views on 14 of the
17 bills under consideration by the Committee. ...
7. Section 5 would repeal outdated statutory requirements that require VA to
provide a veteran with pre-test counseling and to obtain the veteran’s written
informed consent prior to testing the veteran for HIV infection. Those
requirements are not in line with current guidelines issued by the Centers for
Disease Control and Prevention and other health care organizations, which, with
respect to the issue of consent, consider HIV testing to be similar to other blood
tests for which a patient need only give verbal informed consent. According to
many VA providers, the requirements for pre-test counseling and prior written
consent delay testing for HIV infection and, in turn, VA’s ability to identify positive
cases that would benefit from earlier medical intervention. As a result, many
infected patients unknowingly spread the virus to their partners and are not even
aware of the need to present for treatment until complications of the disease
become clinically evident and, often, acute. Testing for HIV infection in routine
clinical settings no longer merits extra measures that VA is now required by law
to provide. Many providers now consider HIV to be a chronic disease for which
continually improving therapies exist to manage it effectively. Repealing the
1988 statutory requirements would not erode the patient’s rights, as VA would,
just like with tests for all other serious conditions, still be legally required to obtain
the patient’s verbal informed consent prior to testing. VA estimates the
discretionary costs associated with enactment of section 5 to be $73,680,000 for
FY 2009 and $301,401,000 over a 10-year period. ...